These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8034238)

  • 1. Influence of age, sex and ABO blood group on activated partial thromboplastin time.
    Fourel V; Gabastou JM; Desroys du Roure F; Ehrhardt N; Robert A
    Haemostasis; 1993; 23(6):321-6. PubMed ID: 8034238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated protein C resistance: the influence of ABO-blood group, gender and age.
    Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L
    Thromb Res; 2006; 117(6):665-70. PubMed ID: 16023702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of ABO type on global coagulation assay results: effect of coagulation factor VIII.
    Choi Q; Kim JE; Kim SY; Han KS; Kim HK
    Clin Chem Lab Med; 2015 Aug; 53(9):1425-32. PubMed ID: 25503670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABO Blood Type and Response of Activated Partial Thromboplastin Time to Dabigatran in Nonvalvular Atrial Fibrillation Patients.
    Suzuki S; Otsuka T; Sagara K; Semba H; Kano H; Matsuno S; Takai H; Kato Y; Uejima T; Oikawa Y; Nagashima K; Kirigaya H; Kunihara T; Yajima J; Sawada H; Aizawa T; Yamashita T
    Circ J; 2015; 79(10):2274-7. PubMed ID: 26310875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reference intervals for coagulation tests in adults with different ABO blood types.
    Chen Z; Dai X; Cao J; Tan X; Chen S; Yu M
    J Clin Lab Anal; 2022 Mar; 36(3):e24269. PubMed ID: 35119133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of sex on activated partial thromboplastin time (aPTT) and prothrombin time (PT) in sheep.
    Leite Carlos MM; Melo MM; Soto-Blanco B
    Vet Ital; 2017 Sep; 53(3):255-258. PubMed ID: 29152708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significantly different coagulation factor activities underlying the variability of 'normal' activated partial thromboplastin time.
    Park KJ; Kwon EH; Ma Y; Park IA; Kim SW; Kim SH; Kim HJ
    Blood Coagul Fibrinolysis; 2012 Jan; 23(1):35-8. PubMed ID: 22027757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verifying reference intervals for coagulation tests by using stored data.
    Aral H; Usta M; Cilingirturk AM; Inal BB; Bilgi PT; Guvenen G
    Scand J Clin Lab Invest; 2011 Dec; 71(8):647-52. PubMed ID: 22017165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-laboratory audit of normal reference ranges and assessment of ABO blood group, gender and age on detected levels of plasma coagulation factors.
    Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L
    Blood Coagul Fibrinolysis; 2005 Nov; 16(8):597-605. PubMed ID: 16269935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-associated developmental changes in the activated partial thromboplastin time (APTT) and causes of prolonged APTT values in healthy Chinese children.
    Li J; Lai X; Yan C; Xu A; Nie L; Zhou Y; Liao C; Ren H
    Clin Chem Lab Med; 2009; 47(12):1531-7. PubMed ID: 19883211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated clotting time test alone is inadequate to optimize therapeutic heparin dosage adjustment during post-cardiopulmonary resuscitational extracorporeal membrane oxygenation (e-CPR).
    Yie K; Chon SH; Na CY
    Perfusion; 2016 May; 31(4):307-15. PubMed ID: 26354740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low intraindividual variability of activated partial thromboplastin time revealed in a population of 10,487 control individuals.
    Ma Y; Huh HJ; Kim SH; Kim HJ
    Blood Coagul Fibrinolysis; 2013 Oct; 24(7):746-8. PubMed ID: 24064902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory coagulation parameters in extremely premature infants born earlier than 27 gestational weeks upon admission to a neonatal intensive care unit.
    Neary E; Okafor I; Al-Awaysheh F; Kirkham C; Sheehan K; Mooney C; Foran A; Corcoran JD; Ni Ainle F; Cotter M; McCallion N
    Neonatology; 2013; 104(3):222-7. PubMed ID: 24030102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Subcutaneous Unfractionated Heparin Prophylaxis on Activated Partial Thromboplastin Time: A Retrospective Evaluation.
    Thompson MH; Wilson SH; Toussaint BL; Jordan CL; Hayes GL; McKinzie BP; Wolf BJ; Field LC
    J Clin Anesth; 2016 Sep; 33():346-50. PubMed ID: 27555191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher morning serum cortisol level predicts increased fibrinogen but not shortened APTT.
    Lippi G; Franchini M; Salvagno GL; Montagnana M; Guidi GC
    J Thromb Thrombolysis; 2008 Oct; 26(2):103-5. PubMed ID: 17629773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of an activated partial thromboplastin time with a Russell viper venom time test in screening for factor V(Leiden) (FVR506Q).
    Sweeney JD; Blair AJ; King TC
    Am J Clin Pathol; 1997 Jul; 108(1):74-7. PubMed ID: 9208981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The determination of activated partial thromboplastin time, coagulate time and thrombin time in patients with epistaxis of indeterminate cause].
    Huang GW; Zhan LL; Huang JD
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Feb; 14(2):51-2. PubMed ID: 12541471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing a new target range for unfractionated heparin for acute coronary syndromes.
    Lee MS; Menon V; Schappert J; Wilentz JR; Singh V; Hochman JS
    J Thromb Thrombolysis; 2004 Apr; 17(2):121-6. PubMed ID: 15306747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of short partial thromboplastin times in a military treatment facility.
    Smith JD; Amundson DE; Harrell T
    Mil Med; 2011 Aug; 176(8):956-8. PubMed ID: 21882790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding events and activated partial thromboplastin time with dabigatran in clinical practice.
    Kawabata M; Yokoyama Y; Sasano T; Hachiya H; Tanaka Y; Yagishita A; Sugiyama K; Nakamura T; Suzuki M; Isobe M; Hirao K
    J Cardiol; 2013 Aug; 62(2):121-6. PubMed ID: 23680005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.